Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024;16(13):841-843.
doi: 10.1080/1750743X.2024.2377954. Epub 2024 Jul 26.

Anti-tumor immunity and vitiligo: from immune-related adverse reactions to protection from cancer

Roberto Mazzetto  1 , Alvise Sernicola  1 , Paola Miceli  1 , Jacopo Tartaglia  1 , Christian Ciolfi  1 , Mauro Alaibac  1
Affiliations
Editorial

Anti-tumor immunity and vitiligo: from immune-related adverse reactions to protection from cancer

Roberto Mazzetto et al. Immunotherapy. 2024.
No abstract available

Keywords: autoimmunity; cancer immunology; checkpoint inhibitors; dermatology; immunotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, stock ownership or options and expert testimony.

Comment on

References

    1. Simeone E, Grimaldi AM, Festino L, et al. Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management. Melan Management. 2019;6:MMT30. doi: 10.2217/mmt-2019-0005 - DOI - PMC - PubMed
    1. Weng Y-C, Ho HJ, Chang Y-L, et al. Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan. Sci Rep. 2021;11:20195. doi: 10.1038/s41598-021-99786-9 - DOI - PMC - PubMed
    1. Paradisi A, Tabolli S, Didona B, et al. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol. 2014;71:1110–1116. doi: 10.1016/j.jaad.2014.07.050 - DOI - PubMed
    1. Hammoud S, Kruis R, Sigurdsson V. Prediction of the occurrence of melanoma and non-melanoma skin cancer in patients with vitiligo. Acta Derm Venerol. 2016;96:106–107. doi: 10.2340/00015555-2179 - DOI - PubMed
    1. Ban L, Labbouz S, Grindlay D, et al. Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018;179:971–972. doi: 10.1111/bjd.16703 - DOI - PubMed

LinkOut - more resources